(Q38118778)

29 August 2017

0 references

Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review (English)

1 reference

29 August 2017

1 reference

J B Echouffo-Tcheugui

1

1 reference

29 August 2017

M K Ali

2

1 reference

29 August 2017

G Roglic

3

1 reference

29 August 2017

R A Hayward

4

1 reference

29 August 2017

K M Narayan

5

1 reference

29 August 2017

language of work or name

1 reference

1 November 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

1272-1292

1 reference

Global prevalence and major risk factors of diabetic retinopathy

29 August 2017

cites work

1 reference

Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study

21 January 2018

1 reference

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

21 January 2018

1 reference

Treatment of diabetic retinopathy

21 January 2018

1 reference

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

21 January 2018

1 reference

Should diabetes retinal screening intervals change?

21 January 2018

1 reference

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

Diabetic retinopathy screening: a systematic review of the economic evidence

21 January 2018

1 reference

The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy

21 January 2018

1 reference

A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy

21 January 2018

1 reference

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

21 January 2018

1 reference

The case for biennial retinopathy screening in children and adolescents

21 January 2018

1 reference

Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus

21 January 2018

1 reference

Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.

21 January 2018

1 reference

Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England

21 January 2018

1 reference

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

21 January 2018

1 reference

Simulation of diabetic eye disease to compare screening policies

21 January 2018

1 reference

Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan.

21 January 2018

1 reference

Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.

21 January 2018

1 reference

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

21 January 2018

1 reference

The evaluation of screening policies for diabetic retinopathy using simulation.

21 January 2018

1 reference

The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy

21 January 2018

1 reference

Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan

21 January 2018

1 reference

Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population.

21 January 2018

1 reference

Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study

21 January 2018

1 reference

A systematic meta-analysis of genetic association studies for diabetic retinopathy

21 January 2018

1 reference

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12274

1 reference

29 August 2017

1 reference